<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article article-type="editorial" dtd-version="2.3" xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Toxicol.</journal-id>
<journal-title>Frontiers in Toxicology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Toxicol.</abbrev-journal-title>
<issn pub-type="epub">2673-3080</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">1248748</article-id>
<article-id pub-id-type="doi">10.3389/ftox.2023.1248748</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Toxicology</subject>
<subj-group>
<subject>Editorial</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Editorial: Women in neurotoxicology: 2021</article-title>
<alt-title alt-title-type="left-running-head">Langley et al.</alt-title>
<alt-title alt-title-type="right-running-head">
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/ftox.2023.1248748">10.3389/ftox.2023.1248748</ext-link>
</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Langley</surname>
<given-names>Monica Renee</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<uri xlink:href="https://loop.frontiersin.org/people/851607/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Villalobos</surname>
<given-names>Alice</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1489606/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Vecchio</surname>
<given-names>Sarah</given-names>
</name>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<xref ref-type="aff" rid="aff5">
<sup>5</sup>
</xref>
<xref ref-type="aff" rid="aff6">
<sup>6</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/849938/overview"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>Department of Molecular Pharmacology and Experimental Therapeutics</institution>, <institution>Mayo Clinic</institution>, <addr-line>Rochester</addr-line>, <addr-line>MN</addr-line>, <country>United States</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>Department of Physical Medicine and Rehabilitation</institution>, <institution>Mayo Clinic</institution>, <addr-line>Rochester</addr-line>, <addr-line>MN</addr-line>, <country>United States</country>
</aff>
<aff id="aff3">
<sup>3</sup>
<institution>Department of Medical Education</institution>, <institution>Texas Tech Health Sciences Center-School of Medicine</institution>, <addr-line>Lubbock</addr-line>, <addr-line>TX</addr-line>, <country>United States</country>
</aff>
<aff id="aff4">
<sup>4</sup>
<institution>Addiction Centre</institution>, <addr-line>Biella</addr-line>, <country>Italy</country>
</aff>
<aff id="aff5">
<sup>5</sup>
<institution>Italian Society of Toxicology (SITOX)</institution>, <addr-line>Milan</addr-line>, <country>Italy</country>
</aff>
<aff id="aff6">
<sup>6</sup>Ser.D <institution>Biella-Drug Addiction Service</institution>, <addr-line>Biella</addr-line>, <country>Italy</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>
<bold>Edited and reviewed by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/805794/overview">Ellen Fritsche</ext-link>, Leibniz-Institut f&#xfc;r Umweltmedizinische Forschung (IUF), Germany</p>
</fn>
<corresp id="c001">&#x2a;Correspondence: Monica Renee Langley, <email>Langley.monica@mayo.edu</email>
</corresp>
</author-notes>
<pub-date pub-type="epub">
<day>04</day>
<month>09</month>
<year>2023</year>
</pub-date>
<pub-date pub-type="collection">
<year>2023</year>
</pub-date>
<volume>5</volume>
<elocation-id>1248748</elocation-id>
<history>
<date date-type="received">
<day>27</day>
<month>06</month>
<year>2023</year>
</date>
<date date-type="accepted">
<day>15</day>
<month>08</month>
<year>2023</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2023 Langley, Villalobos and Vecchio.</copyright-statement>
<copyright-year>2023</copyright-year>
<copyright-holder>Langley, Villalobos and Vecchio</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<related-article id="RA1" related-article-type="commentary-article" journal-id="Front. Toxicol." xlink:href="https://www.frontiersin.org/researchtopic/26739" ext-link-type="uri">Editorial on the Research Topic <article-title>Women in neurotoxicology: 2021</article-title>
</related-article>
<kwd-group>
<kwd>women in STEM</kwd>
<kwd>neurotoxicity</kwd>
<kwd>neurotoxicology</kwd>
<kwd>women in science</kwd>
<kwd>women in neuroscience</kwd>
</kwd-group>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-at-acceptance</meta-name>
<meta-value>Neurotoxicology</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<p>Women&#x2019;s participation in neurotoxicity research is fundamentally important to provide diverse perspectives during study design, execution, analysis, and interpretation of research. This includes a myriad of considerations from sex-specific vulnerabilities, environmental exposures, reproductive and developmental considerations, and underrepresentation in clinical trials, among others. Despite this, less the 30% of researchers worldwide identify as women. This Research Topic was inspired to highlight accomplished women researchers that wished to contribute their first or last author publications across the field of Neurotoxicology. By highlighting women in neurotoxicology, we also provide an opportunity for female researchers to serve as role models for the next-generation.</p>
<p>First, the manuscript by <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/ftox.2021.802542/full">Carolina Caroso dos Santo Dur&#xe3;o et al.</ext-link> examined exposure to environmental tobacco smoke (ETS) during the embryonic stage to see how it affected neuroinflammation in the adult mouse later in life. Multiple sclerosis (MS) is a neurological disorder involving inflammation and demyelination of the central nervous system and that has higher prevalence in women. A common mouse model of MS, called experimental autoimmune encephalomyelitis (EAE), was used in this study. In cell culture and EAE models, ETS exposure resulted in increased neuroinflammatory markers when compared to compressed air, including increased levels of proinflammatory cytokines IL6 and TNF&#x3b1;. Functionally, the ETS exposure resulted in significant worsening of EAE mouse clinical scores.</p>
<p>Next, a paper by <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/ftox.2022.947795/full">Yaghoobi et al.</ext-link> investigated the developmental neurotoxicity potential of specific polychlorinated biphenyls (PCBs) in a zebrafish model. The researchers confirmed different PCB congeners exhibited varying potency in sensitizing ryanodine receptors (RYR) in zebrafish muscle. They found that a subset of these PCB congeners altered photomotor behavior in larval zebrafish, and the pattern of behavioral effects corresponded to the pattern of RYR sensitization, providing <italic>in vivo</italic> evidence supporting the hypothesis that RYR sensitization contributes to the developmental neurotoxicity of PCBs.</p>
<p>A review paper authored by <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/ftox.2022.991787/full">Albrecht et al.</ext-link> summarizes effects of developmental lead (Pb) exposure on ethanol (EtOH) responses in <italic>Caenorhabditis elegans</italic> (<italic>C. elegans</italic>), a powerful model organism used to elucidate toxicant mechanisms. The authors describe morphological changes in dopamine synapses and dopamine-dependent behaviors, providing insights into the neurobiological mechanisms underlying the relationship between these neurotoxicants, and highlights the utility of <italic>C. elegans</italic> as a model for studying combined neurotoxicant effects.</p>
<p>Finally, a rat study by <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/ftox.2022.933300/full">Reyes-Bravo et al.</ext-link> explored the role of chronic exposure to the herbicide atrazine to assess GABAergic and glutamatergic systems. After 1&#xa0;year, there were changes in vertical activity episodes and several genes within the glutamatergic and GABAergic systems in the brain regions explored, which included striatum, nucleus accumbens, ventral midbrain, prefrontal cortex, and hippocampus. Of these, striatum had the most changes, followed by hippocampus. The results in this article spark interest to perform neurochemistry and neurobehavioral analysis especially in models of neurodegenerative disorders affecting basal ganglia.</p>
<p>Overall, the research studies uncover associations between environmental exposures and neurodevelopmental outcomes across several model systems and stages of development. The impact of environmental factors on neurological disease development has implications for the health of women across their lifespan in addition to their families, but also provides research communities valuable insight into the direction of future scientific endeavors <xref ref-type="fig" rid="F1">Figure 1</xref>.</p>
<fig id="F1" position="float">
<label>FIGURE 1</label>
<caption>
<p>Women researchers contribute to the neurotoxicology field by providing their unique insight and using model organisms to uncover mechanisms underlying various environmental exposures relevant to risk and progression of neurodevelopmental, neuropsychiatric, neurodegenerative, and other neurological disorders affecting women and their communities. Schematic generated in Biorender.</p>
</caption>
<graphic xlink:href="ftox-05-1248748-g001.tif"/>
</fig>
</body>
<back>
<sec id="s1">
<title>Author contributions</title>
<p>ML, AV, and SV were all guest editors for the Research Topic. ML wrote the editorial. AV and SV provided edits. All authors contributed to the article and approved the submitted version.</p>
</sec>
<sec sec-type="COI-statement" id="s2">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec sec-type="disclaimer" id="s3">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
</back>
</article>